CD4-Targeted T Cells Rapidly Induce Remissions in Mice with T Cell Lymphoma

OBJECTIVE: To explore the immune cell therapy for T cell lymphoma, we developed CD4-specific chimeric antigen receptor- (CAR-) engineered T cells (CD4CART), and the cytotoxic effects of CD4CART cells were determined in vitro and in vivo. METHODS: CD4CART cells were obtained by transduction of lentiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Jie, Chen, Guanghua, Lv, Hui, XU, Liangjing, LIU, Huiwen, Chen, Tianping, Qu, Lijun, Wang, Jian, Cheng, Lemei, Hu, Shaoyan, Wang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019637/
https://www.ncbi.nlm.nih.gov/pubmed/33855074
http://dx.doi.org/10.1155/2021/6614784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019637/
https://www.ncbi.nlm.nih.gov/pubmed/33855074
http://dx.doi.org/10.1155/2021/6614784

Ejemplares similares